Contact
Please use this form to send email to PR contact of this press release:
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases
TO:
Please use this form to send email to PR contact of this press release:
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases
TO: